MSB 5.24% $1.11 mesoblast limited

$90 a share on COVID ARDS Authorization ?, page-242

  1. 144 Posts.
    lightbulb Created with Sketch. 44
    Do you think they'd only treat 20,000 cases in year 1 though? I think if there are currently 65,000 patients in beds with covid then at least 50-60% would be getting the treatment. But love your numbers, very good basis for predicting potential revenues. What are you using as your price per treatment and profit margin?

    also, CSL made 10 * 225,000,000 pure profit, or revenue?
    Last edited by HungrySponge84: 23/08/21
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.